Avastin Increases Longivity In Women Without Disease Worsening: Genentech
Genentech’s ICON7 study is a multicenter, randomised, open-label, Phase III study in 1,528 women with previously untreated epithelial ovarian, primary peritoneal or fallopian tube carcinoma. The primary endpoint
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.